Charles Hsu

Charles Hsu is an associate practicing intellectual property law with a primary focus on patent litigation and licensing disputes. Mr. Hsu represents technology and pharmaceutical companies in disputes as both plaintiffs and defendants, with particular experience in matters involving  telecommunications, artificial intelligence, semiconductors, small-molecule and biologic therapeutics, and medical devices. Mr. Hsu holds bachelor’s degrees in molecular biology and economics. 

Mr. Hsu's experience spans various jurisdictions, including district courts, state courts, the Patent Trial and Appeal Board (PTAB), the International Trade Commission (ITC), the American Arbitration Association (AAA), and the Judicial Arbitration and Mediation Services (JAMS). Mr. Hsu has been involved in all aspects litigation, including pre-suit investigation, fact and expert discovery, claim construction, trial, and appeal. Mr. Hsu has also presented oral arguments before both the District Court and the PTAB.

Mr. Hsu also maintains an active pro bono practice at Dechert, which includes representation in immigration, employment, and intellectual property matters.

Mr. Hsu has been selected to the Northern California Super Lawyers Rising Stars list each year from 2023 through 2026. 

Mr. Hsu earned his Juris Doctor from Berkeley Law School in 2019, where he was an Associate Editor of the California Law Review. While in law school, Mr. Hsu also advised start-up companies on intellectual property matters, including drafting patent applications and conducting a freedom-to-operate analysis for a start-up biotechnology company.